Professor Adrian Krainer has been named a National Academy of Inventors (NAI) 2018 Fellow. He is being honored for his work on Spinraza®, the first FDA-approved treatment for spinal muscular atrophy (SMA).
NAI Fellows are nominated by their peers; those chosen for the honor demonstrate a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on the quality of life, economic development, and welfare of society. New fellows will be inducted on April 11, 2019, at Space Center Houston.
“Each of these new NAI Fellows embodies the Academy’s mission through their dedication, creativity, and inventive spirit. I look forward to working collaboratively with the new NAI Fellows in growing a global culture of innovation,” said Paul R. Sanberg, President of the NAI.
Earlier this year, Krainer also won the 2019 Breakthrough Prize for Life Sciences, with collaborator C. Frank Bennett of Ionis Pharmaceuticals.